Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial.

Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial. AIDS. 2012 Nov 13; 26(17):2261; author reply 2262-3.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.